1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsClinical Research Extension Award is sponsored by Department of Defense (DoD) Breast Cancer Research Program. Supports research that extends data collection, follow-up, and analysis of breast cancer clinical studies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. mil** website belongs to an official U.S. Department of War organization.
##### DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS # Transforming Health Care through Innovative and Impactful Research * FY26 Funded Research Programs * Alcohol and Substance Use Disorders * Amyotrophic Lateral Sclerosis * Combat Readiness-Medical * Duchenne Muscular Dystrophy * Joint Warfighter Medical * Reconstructive Transplant Research * Traumatic Brain Injury and Psychological Health * Tuberous Sclerosis Complex * Previously Funded Research Programs * Chronic Pain Management * Neurotoxin Exposure Treatment Parkinson's * Orthotics and Prosthetics Outcomes * Other Defense Health Program Support * Defense Medical Research and Development * Archived Research Programs * Start Pre-Application (eBRAP) * Avoiding Research Duplication * Program Consumer Reviewer Requirements * Frequently Asked Questions * Consumer Nomination Application * Funded Research & Impact * Impactful Research Outcomes * Two Tiered Review Process **Sorry, but the page you were trying to view does not exist.
** Note: Documents in Portable Document Format (PDF) require Adobe Acrobat Reader to view, download Adobe Acrobat Reader. 1077 Patchel Street Fort Detrick, MD 21702-5024 About Us The CDMRP originated in 1992 via a Congressional appropriation to foster novel approaches to biomedical research in response to the expressed needs of its stakeholders-the American public, the military, and Congress.
According to the current listing, eligibility includes: Domestic non-profit and for-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State or local governments, and eligible agencies of the Federal government. Confirm the full requirements in the official notice before applying.
The current listing shows up to $400,000 per year for up to four years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Clinical Research Extension Award is funded by Department of Defense (DoD) Breast Cancer Research Program. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read article